Related Experiment Video
Updated: Jul 16, 2026

A Functional Assay for Gap Junctional Examination; Electroporation of Adherent Cells on Indium-Tin Oxide
Published on: October 18, 2014
Intracellular transport, assembly, and degradation of wild-type and disease-linked mutant gap junction proteins
J K VanSlyke1, S M Deschenes, L S Musil
1Vollum Institute for Advanced Biomedical Research, Oregon Health Sciences University, Portland, Oregon 97201, USA.
Abstract:
More than 130 different mutations in the gap junction integral plasma membrane protein connexin32 (Cx32) have been linked to the human peripheral neuropathy X-linked Charcot-Marie-Tooth disease (CMTX). How these various mutants are processed by the cell and the mechanism(s) by which they cause CMTX are unknown. To address these issues, we have studied the intracellular transport, assembly, and degradation of three CMTX-linked Cx32 mutants stably expressed in PC12 cells. Each mutant had a distinct fate: E208K Cx32 appeared to be retained in the endoplasmic reticulum (ER), whereas both the E186K and R142W mutants were transported to perinuclear compartments from which they trafficked either to lysosomes (R142W Cx32) or back to the ER (E186K Cx32). Despite these differences, each mutant was soluble in nonionic detergent but unable to assemble into homomeric connexons. Degradation of both mutant and wild-type connexins was rapid (t(1/2) < 3 h) and took place at least in part in the ER by a process sensitive to proteasome inhibitors. The mutants studied are therefore unlikely to cause disease by accumulating in degradation-resistant aggregates but instead are efficiently cleared from the cell by quality control processes that prevent abnormal connexin molecules from traversing the secretory pathway.
Insights
Mutations in connexin32 (Cx32) cause X-linked Charcot-Marie-Tooth disease (CMTX). This study reveals Cx32 mutants are rapidly degraded by cellular quality control, not aggregated, explaining disease mechanisms.
Area of Science:
- Cell Biology
- Neuroscience
- Genetics
Background:
- Over 130 mutations in connexin32 (Cx32) are linked to X-linked Charcot-Marie-Tooth disease (CMTX), a human peripheral neuropathy.
- The cellular processing and disease mechanisms of Cx32 mutants remain largely unknown.
Purpose of the Study:
- To investigate the intracellular transport, assembly, and degradation of three CMTX-linked Cx32 mutants.
- To elucidate how cellular quality control mechanisms handle these abnormal Cx32 proteins.
Main Methods:
- Stable expression of three CMTX-linked Cx32 mutants (E208K, E186K, R142W) in PC12 cells.
- Analysis of intracellular transport using cell imaging.
- Assessment of protein assembly, solubility, and degradation pathways (ER, lysosomes, proteasomes).
Main Results:
- Each Cx32 mutant exhibited distinct intracellular trafficking patterns: retention in ER (E208K), perinuclear localization with lysosomal (R142W) or ER (E186K) trafficking.
- All mutants were soluble but failed to form functional homomeric connexons.
- Both mutant and wild-type Cx32 proteins were rapidly degraded (t½ < 3 h), partly in the ER via proteasome-sensitive pathways.
Conclusions:
- CMTX-linked Cx32 mutants do not cause disease through aggregation but are efficiently cleared by cellular quality control.
- Quality control mechanisms prevent abnormal Cx32 proteins from progressing through the secretory pathway, impacting peripheral nerve function.
Related Concept Videos
Contact-dependent Signaling
Gap Junctions
In animal cells, gap junctions are formed...
Gap Junctions
Golgi Matrix Proteins
One of the first identified Golgi matrix proteins was GM130, a rod-like protein located in the cis-Golgi. Subsequently, many Golgi...
Transport Across the Golgi
Overview of Cell-Cell Junctions
Occluding or Tight Junctions
Tight...
Gap Junctions

